Pharma Journalist - Page 874 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Avenue Therapeutics receives Notice of Allowance from USPTO for Administration of Intravenous Tramadol

GTO appoints Kieran Walsh as president of US Operations

MSD submits application to combine DPP-4 inhibitor and SGLT2 inhibitor for treatment type-2 diabetes

Acasti Pharma invited to present the CaPre study results at National Lipid Association Scientific Sessions

XOMA Earns $10 Million Milestone Payment as Another of its Licensed Assets

FDA approves Jubilant’s Amlodipine and Olmesartan Medoxomil Tablets

FDA expands approved use of Kalydeco to treat cystic fibrosis

FDA grants Octapharma orphan drug designation for Octagam 10%

Lilly selects Cogstate as preferred provider for Alzheimer Disease Platform

Concert Pharmaceuticals Announces Clinical Hold on CTP-543